Edition:
India

People: DexCom Inc (DXCM.OQ)

DXCM.OQ on NASDAQ Stock Exchange Global Select Market

233.94USD
24 Jan 2020
Change (% chg)

$-1.66 (-0.70%)
Prev Close
$235.60
Open
$237.77
Day's High
$238.44
Day's Low
$233.18
Volume
163,900
Avg. Vol
277,004
52-wk High
$242.14
52-wk Low
$107.44

Augustinos, Nicholas 

Mr. Nicholas Augustinos serves as Independent Director of DexCom Inc., since November 20, 2009. Since December 2015 through December 2018, Mr. Augustinos has served as President and CEO of Aver, Inc., a company specializing in bundled payment and analytics solutions. He served on the Board of Directors of Aver since September 2014. Starting January 2019 he was elected Chairman of the Board of Directors of Aver. From November 2011 until December 2015, Mr. Augustinos worked for Cardinal Health, Inc. as its Senior Vice President for Health Information Services and Strategy. From March 2005 through October 2011, Mr. Augustinos worked for Cisco Systems, Inc. (“Cisco”), a networking company. At Cisco, he held various positions, including Director of Cisco’s Internet Business Solutions Group, Senior Director, Global Healthcare Solutions Group, and Senior Director of Global Healthcare Operations. In January 2015, Mr. Augustinos was appointed to the Board of Directors of the California Health Care Foundation (“CHCF”), which seeks to improve care for all Californians through innovations that improve quality, increase efficiency, and lower the cost of care. Prior to CHCF he served on the Board of Directors of the SCAN Foundation, an organization dedicated to advancing the development of a sustainable continuum of quality care for seniors, from June 2011 until December 2014. Mr. Augustinos served on the Board of Directors of Audax Health, now Rally, from March 2012 until February 2014. With a 31-year career in healthcare and healthcare technology, Mr. Augustinos has broad managerial, consulting and business development experience in the private and public sectors. Mr. Augustinos has worked with a diverse range of leading healthcare delivery systems, healthcare insurers and government organizations globally and brings to the Board significant business and market development experience with growth companies.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 317,998
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 317,998

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kevin Sayer

9,554,120

Quentin Blackford

3,391,640

Jake Leach

--

Donald Abbey

2,919,160

Andrew Balo

3,174,640

Richard Doubleday

3,207,460
As Of  31 Dec 2018